In vitro and in vivo suppression of GJB2 expression by RNA interference.

Mutations in GJB2 (gap junction protein, beta-2) are the major cause of autosomal recessive non-syndromic hearing loss. A few allele variants of this gene also cause autosomal dominant non-syndromic hearing loss as a dominant-negative consequence of expression of the mutant protein. Allele-specific gene suppression by RNA interference (RNAi) is a potentially attractive strategy to prevent hearing loss caused by this mechanism. In this proof-of-principle study, we identified a potent GJB2-targeting short interfering RNA (siRNA) to post-transcriptionally silence the expression of the R75W allele variant of GJB2 in cultured mammalian cells. In a mouse model, this siRNA duplex selectively suppressed GJB2(R75W) expression by >70% of control levels, thereby preventing hearing loss. The level of endogenous murine Gjb2 expression was not affected. Our data show that RNAi can be used with specificity and efficiency in vivo to protect against hearing loss caused as a dominant-negative consequence of mutant gene expression.

[1]  S. Kaul,et al.  Know-how of RNA interference and its applications in research and therapy. , 2004, Mutation research.

[2]  H. Paulson,et al.  RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia , 2004, Nature Medicine.

[3]  N. Caplen,et al.  Gene Therapy Progress and Prospects. Downregulating gene expression: the impact of RNA interference , 2004, Gene Therapy.

[4]  Eric Westhof,et al.  Single Processing Center Models for Human Dicer and Bacterial RNase III , 2004, Cell.

[5]  R. Shepherd,et al.  Surface microstructure of the perilymphatic space: implications for cochlear implants and cell- or drug-based therapies. , 2004, Archives of otolaryngology--head & neck surgery.

[6]  F. Leenders,et al.  Inducible shRNA expression for application in a prostate cancer mouse model. , 2003, Nucleic acids research.

[7]  M. Wood,et al.  Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference. , 2003, Human molecular genetics.

[8]  R. Smith,et al.  Genetic screening for hearing loss. , 2003, Clinical otolaryngology and allied sciences.

[9]  Haibin Xia,et al.  Allele-specific silencing of dominant disease genes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Anton P. McCaffrey,et al.  Inhibition of hepatitis B virus in mice by RNA interference , 2003, Nature Biotechnology.

[11]  Toshimitsu Kobayashi,et al.  Transgenic expression of a dominant-negative connexin26 causes degeneration of the organ of Corti and non-syndromic deafness. , 2003, Human molecular genetics.

[12]  Andrew Forge,et al.  Mutations in the gene for connexin 26 (GJB2) that cause hearing loss have a dominant negative effect on connexin 30. , 2003, Human molecular genetics.

[13]  W. Filipowicz,et al.  Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP , 2002, The EMBO journal.

[14]  B. Samuelsson,et al.  Ribonuclease activity and RNA binding of recombinant human Dicer , 2002, The EMBO journal.

[15]  Michael T. McManus,et al.  Gene silencing in mammals by small interfering RNAs , 2002, Nature Reviews Genetics.

[16]  Henning Urlaub,et al.  Single-Stranded Antisense siRNAs Guide Target RNA Cleavage in RNAi , 2002, Cell.

[17]  R. Bernards,et al.  Stable suppression of tumorigenicity by virus-mediated RNA interference. , 2002, Cancer cell.

[18]  David L. Lewis,et al.  Efficient delivery of siRNA for inhibition of gene expression in postnatal mice , 2002, Nature Genetics.

[19]  K. Willecke,et al.  Targeted Ablation of Connexin26 in the Inner Ear Epithelial Gap Junction Network Causes Hearing Impairment and Cell Death , 2002, Current Biology.

[20]  Ali Ehsani,et al.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells , 2002, Nature Biotechnology.

[21]  A. Fire,et al.  Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference. , 2002, Human molecular genetics.

[22]  T. Tuschl,et al.  Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate , 2001, The EMBO journal.

[23]  P. Zamore,et al.  ATP Requirements and Small Interfering RNA Structure in the RNA Interference Pathway , 2001, Cell.

[24]  A. Taylor,et al.  trans-dominant inhibition of connexin-43 by mutant connexin-26: implications for dominant connexin disorders affecting epidermal differentiation. , 2001, Journal of cell science.

[25]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[26]  A. Lalwani,et al.  Cochlear gene delivery through an intact round window membrane in mouse. , 2001, Human gene therapy.

[27]  G. Utermann,et al.  De novo mutation of the connexin 26 gene associated with dominant non-syndromic sensorineural hearing loss , 2001, Human Genetics.

[28]  Anil K. Lalwani,et al.  A surgical approach appropriate for targeted cochlear gene therapy in the mouse , 2001, Hearing Research.

[29]  A. Caudy,et al.  Role for a bidentate ribonuclease in the initiation step of RNA interference , 2001 .

[30]  T. Tuschl,et al.  RNA interference is mediated by 21- and 22-nucleotide RNAs. , 2001, Genes & development.

[31]  J. Common,et al.  Connexin 26 Expression and Mutation Analysis in Epidermal Disease , 2001, Cell communication & adhesion.

[32]  K. Beisel,et al.  Longitudinal gradients of KCNQ4 expression in spiral ganglion and cochlear hair cells correlate with progressive hearing loss in DFNA2. , 2000, Brain research. Molecular brain research.

[33]  C. Petit,et al.  KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Josef M. Miller,et al.  Technical report: chronic and acute intracochlear infusion in rodents , 2000, Hearing Research.

[35]  Y. Matsubara,et al.  Novel mutations in the connexin 26 gene (GJB2) responsible for childhood deafness in the Japanese population. , 2000, American journal of medical genetics.

[36]  W. Kimberling,et al.  Prevalent connexin 26 gene (GJB2) mutations in Japanese , 2000, Journal of medical genetics.

[37]  M. King,et al.  Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13) , 1999, Nature Genetics.

[38]  D. Spray.  Gap Junction-Mediated Intercellular Signaling in Health and Disease , 1999, Trends in Neurosciences.

[39]  V. Sheffield,et al.  Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. , 1999, JAMA.

[40]  H. Ostrer,et al.  Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. , 1998, The New England journal of medicine.

[41]  Thomas W. White,et al.  Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma , 1998, Human Genetics.

[42]  R. Bruzzone,et al.  Connexin 26 gene linked to a dominant deafness , 1998, Nature.

[43]  X. Estivill,et al.  Connexin-26 mutations in sporadic and inherited sensorineural deafness , 1998, The Lancet.

[44]  C. Petit,et al.  Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. , 1997, Human molecular genetics.

[45]  H. Strey,et al.  Improved DNA: liposome complexes for increased systemic delivery and gene expression , 1997, Nature Biotechnology.

[46]  D. Kelsell,et al.  Connexin 26 mutations in hereditary non-syndromic sensorineural deafness , 1997, nature.

[47]  K. Kemphues,et al.  par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed , 1995, Cell.

[48]  P. Hwu.  Gene therapy: progress and prospects. , 1994, Contemporary urology.

[49]  L. Duckert,et al.  Cochlear Communication Routes in the Guinea Pig—Spiral Ganglia and Osseous Spiral Laminae: An Electron Microscope Study Using Microsphere Tracers , 1978, Otolaryngology.

[50]  S. Barik,et al.  Inhibition of respiratory viruses by nasally administered siRNA , 2005, Nature Medicine.

[51]  Hong Yang,et al.  Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene , 2005, Nature Medicine.

[52]  N. Kumar,et al.  Molecular biology of the interactions between connexins. , 1999, Novartis Foundation symposium.